Cargando…
Can Systems Biology Understand Pathway Activation? Gene Expression Signatures as Surrogate Markers for Understanding the Complexity of Pathway Activation
Cancer is thought to be caused by a sequence of multiple genetic and epigenetic alterations which occur in one or more of the genes controlling cell cycle progression and signaling transduction. The complexity of carcinogenic mechanisms leads to heterogeneity in molecular phenotype, pathology, and p...
Autores principales: | Itadani, Hiraku, Mizuarai, Shinji, Kotani, Hidehito |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694555/ https://www.ncbi.nlm.nih.gov/pubmed/19517027 http://dx.doi.org/10.2174/138920208785133235 |
Ejemplares similares
-
Expression ratio of CCND1 to CDKN2A mRNA predicts RB1 status of cultured cancer cell lines and clinical tumor samples
por: Mizuarai, Shinji, et al.
Publicado: (2011) -
Discovery of gene expression-based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor
por: Mizuarai, Shinji, et al.
Publicado: (2009) -
Mouse gastric tumor models with prostaglandin E(2 )pathway activation show similar gene expression profiles to intestinal-type human gastric cancer
por: Itadani, Hiraku, et al.
Publicado: (2009) -
Inhibition of p70S6K2 down-regulates Hedgehog/GLI pathway in non-small cell lung cancer cell lines
por: Mizuarai, Shinji, et al.
Publicado: (2009) -
Biomarker discovery by integrated joint non-negative matrix factorization and pathway signature analyses
por: Fujita, Naoya, et al.
Publicado: (2018)